Molnupiravir May Be Effective Against COVID-19 in Vaccinated, Unvaccinated Adults
Researchers evaluated the antiviral efficacy of molnupiravir among vaccinated and unvaccinated patients infected with a broad range of COVID-19 variants.
Researchers evaluated the antiviral efficacy of molnupiravir among vaccinated and unvaccinated patients infected with a broad range of COVID-19 variants.
Regardless of vaccination status, adults hospitalized for COVID-19 infection are at increased risk for acute thromboembolism
Researchers assessed maternal, neonatal, and fetal outcomes associated COVID-19 vaccination during pregnancy.
Researched compared standard vs variable thromboprophylaxis strategies on the risk of mortality among patients hospitalized with COVID-19.
Using a symptom tracker app, researchers assessed the risk for long COVID among patients infected with the Delta or the Omicron variant between 2 time periods.
Researchers sought to determine whether prespecified outcomes were different in endovascular thrombectomy with alteplase compared with EVT alone in patients hospitalized with acute ischemic stroke.